Perimenopause is a time in a woman's life where fertility may vary depending upon her age and her reproductive stage and has been defined as the transition period prior to menopause that is characterized by irregular menses, hormonal changes, vasomotor symptoms, and declining fertility (Casper, 2020). Fertility tracking during this time in a woman's reproductive stage has not been widely studied. Employing the use of Luteinizing Hormone Urine Assay sticks, an electronic hormonal monitor device or mucus, we propose a set of guidelines to determine the potentially fertile times of a woman's cycle based on staging according to the Stages of Reproductive Aging Workshop (STRAW) criteria and illustrate their application with three case reports.
BaradD. H.WeghoferA.GleicherN.. 2009. “How predictive of basic pregnancy potential are extremly low levels of anti-müllerian hormone (AMH)?” Fertility and Sterility92, no. 3: S178–S179. https://doi.org/10.1016/j.fertnstert.2009.07.1361.
2.
BarronM. L.VanderkolkK.RavieleK.. 2018. “Finding the Fertile Phase: Low-Cost Luteinizing Hormone Sticks Versus Electronic Fertility Monitor.” American Journal of Maternal and Child Nursing43, no. 3: 153–157. https://doi.org/10.1097/NMC.0000000000000422.
3.
CasperR. F.2020. Clinical manifestations and diagnosis of menopause. UpToDate. Literature review current through March 20, 2021. This topic last updated: March 20, 2020. Accessed April 28th, 2021https://www.uptodate.com/contents/search.
4.
FehringR. J.MuQ.. 2014. “Cohort Efficacy Study of Natural Family Planning among Perimenopause Age Women.” Journal of Obstetric, Gynecologic & Neonatal Nursing43: 351–358. 10.1111/1552-6909.12307.
5.
FlynnA. M.JamesP.CollinsW. P.RoystonP.. 1991. “Symptothermal and hormonal markers of potential fertility in climacteric women.” American Journal of Obstetrics and Gynecology165, 6: 1987–1989. https://doi.org/10.1016/S0002-9378(11)90560-2.
6.
GrayR. H.1979. “Biological and social interactions in the determination of late fertility.” Journal of Biosocial Science11, Suppl. S6: 97–115. 10.1017/S0021932000024329.
7.
HarlowS. D.GassM.HallJ. E.LoboR.MakiP.RebarR. W.ShermanS.SlussP. M.de VilliersT. J.. 2012. “Executive summary of the Stages of Reproductive Aging Workshop + 10.” Menopause19, no. 4: 387–395. https://doi:10.1097/gme.0b013e31824d8f40.
El KhoudaryS. R.GreendaleG.CrawfordS. L.AvisN. E.BrooksM. M.ThurstonR. C.Karvonen-GutierrezC.WaetjenL. E.MatthewsK.. 2019. “The menopause transition and women’s health at midlife: a progress report from the Study of Women’s Health Across the Nation (SWAN).” Menopause: The Journal of the North American Menopause Society26, no. 10: 1213–1227. 10.1097/GME.0000000000001424.
10.
LeivaR. A.BouchardT. P.AbdullahS. H.EcochardR.. 2017. “Urinary Luteinizing Hormone Tests: Which Concentration Threshold Best Predicts Ovulation?” Frontiers in Public Health5: 320. https://doi.org/10.3389/fpubh.2017.00320.
11.
LauferN.SimonA.SamueloffA.YaffeH.MilwidskyA.GielchinskyY.. 2004. “Successful spontaneous pregnancies in women older than 45 years.” Fertility and Sterility81, no. 5: 1328–1332. 10.1016/j.fertnstert.2003.09.056.
12.
MetcalfM. G.1979. “Incidence of ovulatory cycles in women approaching the menopause.” Journal of Biosocial Science11: 39–48.
13.
O'ConnorK. A.FerrellR.BrindleE.TrumbleB.ShoferJ.HolmanD. J.WeinsteinM.. 2009. “Progesterone and ovulation across stages of the transition to menopause.” Menopause16, no. 6: 1178–1187. 10.1097/gme.0b013e3181aa192d.
14.
StanczykF. Z.ClarkeN. J.. 2014. “Measurement of Estradiol-Challenges Ahead.” The Journal of Clinical Endocrinology & Metabolism99, 1: 56–58. https://doi.org/10.1210/jc.2013-2905.
